Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-10, Vol.30, p.v120-v121 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v121 |
|---|---|
| container_issue | |
| container_start_page | v120 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Kish, J. Trocio, J. Miller, T. Nero, D. Liassou, D. Liu, X. McRoy, L. Feinberg, B. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz242.033 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz242_033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz242_033</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1333-e341fa49a5686962e96f21a560390ab8d18473052c1956fca426772d98aa3c53</originalsourceid><addsrcrecordid>eNot0EtLAzEUBeAsFKyPH-Du7mXaPOaVpRRfUBC0roc7mRuMpJMhCZXWP-9IXd1zz-IsPsZuBV8KrtUKxzGMZrUbjrKUS67UGVtwLVXRVKq8YJcpfXHOay31gv28EfriO0Q_AFlLJrs9jZQSBAvWxZQL70aCCX0fjDPe9XAHnnIMx-AJbIiwo4wpY3YG-khzBIOjoQglHAhjginMHU5TDHv04EbInwQf79fs3KJPdPN_r9j28WG7fi42r08v6_tNYYRSqiBVCoulxqpua11L0rWVYv640hz7dhBt2SheSSN0VVuDpaybRg66RVSmUldMnGZNDClFst0U3Q7joRO8-wPrTmDdCaybwdQvce5kbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kish, J. ; Trocio, J. ; Miller, T. ; Nero, D. ; Liassou, D. ; Liu, X. ; McRoy, L. ; Feinberg, B.</creator><creatorcontrib>Kish, J. ; Trocio, J. ; Miller, T. ; Nero, D. ; Liassou, D. ; Liu, X. ; McRoy, L. ; Feinberg, B.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz242.033</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.v120-v121</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1333-e341fa49a5686962e96f21a560390ab8d18473052c1956fca426772d98aa3c53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Kish, J.</creatorcontrib><creatorcontrib>Trocio, J.</creatorcontrib><creatorcontrib>Miller, T.</creatorcontrib><creatorcontrib>Nero, D.</creatorcontrib><creatorcontrib>Liassou, D.</creatorcontrib><creatorcontrib>Liu, X.</creatorcontrib><creatorcontrib>McRoy, L.</creatorcontrib><creatorcontrib>Feinberg, B.</creatorcontrib><title>Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNot0EtLAzEUBeAsFKyPH-Du7mXaPOaVpRRfUBC0roc7mRuMpJMhCZXWP-9IXd1zz-IsPsZuBV8KrtUKxzGMZrUbjrKUS67UGVtwLVXRVKq8YJcpfXHOay31gv28EfriO0Q_AFlLJrs9jZQSBAvWxZQL70aCCX0fjDPe9XAHnnIMx-AJbIiwo4wpY3YG-khzBIOjoQglHAhjginMHU5TDHv04EbInwQf79fs3KJPdPN_r9j28WG7fi42r08v6_tNYYRSqiBVCoulxqpua11L0rWVYv640hz7dhBt2SheSSN0VVuDpaybRg66RVSmUldMnGZNDClFst0U3Q7joRO8-wPrTmDdCaybwdQvce5kbg</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Kish, J.</creator><creator>Trocio, J.</creator><creator>Miller, T.</creator><creator>Nero, D.</creator><creator>Liassou, D.</creator><creator>Liu, X.</creator><creator>McRoy, L.</creator><creator>Feinberg, B.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US</title><author>Kish, J. ; Trocio, J. ; Miller, T. ; Nero, D. ; Liassou, D. ; Liu, X. ; McRoy, L. ; Feinberg, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1333-e341fa49a5686962e96f21a560390ab8d18473052c1956fca426772d98aa3c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kish, J.</creatorcontrib><creatorcontrib>Trocio, J.</creatorcontrib><creatorcontrib>Miller, T.</creatorcontrib><creatorcontrib>Nero, D.</creatorcontrib><creatorcontrib>Liassou, D.</creatorcontrib><creatorcontrib>Liu, X.</creatorcontrib><creatorcontrib>McRoy, L.</creatorcontrib><creatorcontrib>Feinberg, B.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kish, J.</au><au>Trocio, J.</au><au>Miller, T.</au><au>Nero, D.</au><au>Liassou, D.</au><au>Liu, X.</au><au>McRoy, L.</au><au>Feinberg, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>v120</spage><epage>v121</epage><pages>v120-v121</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz242.033</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-10, Vol.30, p.v120-v121 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz242_033 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A09%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real-world%20effectiveness%20of%20first-line%20palbociclib%20+%20letrozole%20for%20metastatic%20breast%20cancer%204%20years%20post%20approval%20in%20the%20US&rft.jtitle=Annals%20of%20oncology&rft.au=Kish,%20J.&rft.date=2019-10&rft.volume=30&rft.spage=v120&rft.epage=v121&rft.pages=v120-v121&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz242.033&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz242_033%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |